share_log

Vanda Pharmaceuticals Q2 EPS $0.05 Misses $0.11 Estimate, Sales $64.40M Miss $67.00M Estimate

Benzinga Real-time News ·  Aug 3, 2022 16:30

Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.11 by 54.55 percent. This is a 70.59 percent decrease over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $64.40 million which missed the analyst consensus estimate of $67.00 million by 3.88 percent. This is a 5.15 percent decrease over sales of $67.90 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment